People · Operator
Named in public records as an officer, director or promoter · active 2008–2008 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardax Pharmaceuticals Inc | — | Biotechnology | Pre-Seed | $1.1M | $30.4M | 2008 |
Thomas H. Goodin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas H. Goodin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nicholas Mitsakos | 1 | 4 |
| David G. Watumull | 1 | 4 |
| Fredric J. Pashkow | 1 | 1 |
| Nicholas J. Mitsakos | 1 | 1 |
| Frank J. Herringer | 1 | 1 |
| Frederic J. Pashkow | 1 | 1 |
| Frank Herringer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.